Hydrogen sulfide supplementation as a potential treatment for primary mitochondrial diseases

Primary mitochondrial diseases (PMD) are amongst the most common inborn errors of metabolism causing fatal outcomes within the first decade of life. With marked heterogeneity in both inheritance patterns and physiological manifestations, these conditions present distinct challenges for targeted drug...

Täydet tiedot

Bibliografiset tiedot

Päätekijät:	Luke Slade, Colleen S. Deane, Nathaniel J. Szewczyk, Timothy Etheridge, Matthew Whiteman
Aineistotyyppi:	Artigo
Kieli:	Inglês
Julkaistu:	Elsevier 2024-05-01
Sarja:	Pharmacological Research
Aiheet:	Hydrogen sulfide Primary mitochondrial disease Therapeutics Mitochondria Persulfidation
Linkit:	http://www.sciencedirect.com/science/article/pii/S1043661824001245
Tagit:	Lisää tagi Ei tageja, Lisää ensimmäinen tagi!